Factory 99% Gts-21 Powder CAS 148372-04-7 Chemical Intermediate Gts-21

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A885
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Gts-21
• CAS: 148372-04-7
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Chemical Intermediate
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Gts-21
Appearance	White Powder
CAS NO.	148372-04-7
Storage	Keep in a cool, dry, dark location

 

GTS-21, also known by its chemical name 3-(2,4-dimethoxybenzylidene)anabaseine dihydrochloride, is a synthetic compound that belongs to the class of partial nicotinic acetylcholine receptor agonists. It is specifically designed to target and interact with nicotinic receptors in the brain, which are involved in a variety of physiological and cognitive processes. GTS-21 has garnered attention in research for its potential therapeutic applications, particularly in the areas of cognitive enhancement and the treatment of neurological disorders.

 

1. Cognitive Enhancement: GTS-21 has shown promise in improving cognitive functions such as memory, attention, and learning. Research suggests that it may enhance cholinergic transmission in the brain, leading to improved cognitive performance in healthy individuals as well as those with cognitive impairments.

2. Neurological Disorders: The compound is being investigated for its potential to treat various neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. By modulating nicotinic receptor activity, GTS-21 may help alleviate symptoms and slow the progression of these conditions.

3. Addiction Treatment: GTS-21 has also shown potential in the treatment of addiction, particularly nicotine addiction. It is believed to reduce cravings and withdrawal symptoms by modulating the nicotinic receptors involved in the addiction process.

1. Nicotinic Receptor Agonist: GTS-21 acts as a partial agonist at nicotinic acetylcholine receptors, meaning it binds to the receptor and activates it to a certain extent, but not as fully as a full agonist. This partial activation can lead to beneficial effects on cognitive and neurological function.

2. Neuroprotective Effects: The compound has demonstrated neuroprotective properties, which may contribute to its potential in treating neurological disorders. It is thought to protect neurons from damage and promote their survival and function.

3. Cholinergic Enhancement: GTS-21 enhances cholinergic transmission in the brain, which is crucial for cognitive processes such as memory and learning. By increasing the availability and activity of acetylcholine, GTS-21 may improve cognitive performance and slow the decline associated with aging and neurological diseases.